Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tertatolol: a beta-blocker with unique effects on human glomerular cell function

P Shultz1, L Raij

  • 1Renal Section (IIIJ), VA Medical Center, Minneapolis, Minn 55417.

Cardiology
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetically conditioned interaction among microRNA-155, alpha-klotho, and intra-renal RAS in male rats: Link to CKD progression.

Physiological reports·2024
Same author

Effects of the reactive oxygen species hydrogen peroxide and hypochlorite on endothelial nitric oxide production.

Hypertension (Dallas, Tex. : 1979)·2001
Same author

Cigarette smoke-induced endothelium dysfunction: role of superoxide anion.

Journal of hypertension·2001
Same author

Workshop: hypertension and cardiovascular risk factors: role of the angiotensin II-nitric oxide interaction.

Hypertension (Dallas, Tex. : 1979)·2001
Same author

Antifibrotic effects of N-acetyl-seryl-aspartyl-Lysyl-proline on the heart and kidney in aldosterone-salt hypertensive rats.

Hypertension (Dallas, Tex. : 1979)·2001
Same author

Prenatally protein-malnourished rats are less sensitive to the amnestic effects of medial septal infusions of chlordiazepoxide.

Behavioural pharmacology·2000
Same journal

Reply Letter.

Cardiology·2026
Same journal

Aortic Valve Sclerosis: More Than an Incidental Echocardiographic Finding.

Cardiology·2026
Same journal

Can resting segmental strain identify obstructive coronary artery disease in chronic coronary syndrome patients referred to CABG?

Cardiology·2026
Same journal

Mortality Impact of Stroke and Major Bleeding Across the Ejection Fraction Spectrum in Patients Hospitalized for Acute Heart Failure With Prevalent Atrial Fibrillation.

Cardiology·2026
Same journal

Impact of Inflammatory Disorders on Outcomes in Acute Heart Failure: A Nationwide Analysis.

Cardiology·2026
Same journal

Predictors and Clinical Impact of Tricuspid Regurgitation After Pericardiectomy for Constrictive Pericarditis.

Cardiology·2026
See all related articles

Tertatolol, a beta-blocker, inhibits human mesangial cell (HMC) proliferation by reducing 3H-thymidine incorporation, particularly when stimulated by growth factors. This study reveals tertatolol

Area of Science:

  • Nephrology
  • Pharmacology
  • Cell Biology

Background:

  • Tertatolol exhibits unique renal vasodilatory effects, impacting microcirculation.
  • Vasodilators often inhibit human mesangial cell (HMC) proliferation.
  • Investigating tertatolol's impact on HMC proliferation is warranted.

Purpose of the Study:

  • To determine the effects of tertatolol on human mesangial cell (HMC) proliferation.
  • To assess tertatolol's influence on 3H-thymidine incorporation in HMC.
  • To evaluate tertatolol's effect on angiotensin II-induced HMC contraction.

Main Methods:

  • Human mesangial cells (HMC) were incubated with tertatolol and various mitogens (serum, PDGF, thrombin).
  • 3H-thymidine incorporation was measured to assess proliferation.

Related Experiment Videos

  • Cell surface area was measured to evaluate contraction in response to angiotensin II.
  • Main Results:

    • Tertatolol significantly reduced 3H-thymidine incorporation in HMC stimulated by serum, PDGF, and thrombin.
    • Tertatolol inhibited the increase in HMC number over seven days in serum.
    • Tertatolol counteracted angiotensin II-induced reduction in HMC surface area.

    Conclusions:

    • Tertatolol demonstrates inhibitory effects on human mesangial cell (HMC) proliferation.
    • These findings suggest tertatolol may modulate renal cellular responses.
    • Further research into tertatolol's mechanism in renal microcirculation is indicated.